Study of Glycemic Variability, Hypoglycemia Using Continuous Glucose Monitoring in Type 2 Diabetes Mellitus Changed from Basal-Bolus Therapy to Basal-GLP-1 RA Therapy

Study of Glycemic Variability, Hypoglycemia Using Continuous Glucose Monitoring in Type 2 Diabetes Mellitus Changed from Basal-Bolus Therapy to Basal-GLP-1 RA Therapy - Study of switching from BBT to BGT under CGM in T2DM

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000042895

Enrollment

Registered

2021-01-04

Start date

2019-04-20

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes Mellitus

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Adult type2 diabetic patients/Patients with HbA1c within management goals/Patients who receive only relatively small amount of bolus insulin/Patients wearing CGM when switching treatments

Exclusion criteria

Exclusion criteria: Patients with contraindicated duraglutide

Design outcomes

Primary

Measure	Time frame
Time Below Range and Time In Range for 3 days before and after treatment change.	—

Secondary

Measure	Time frame
Mean glucose levels, %CV for 3 days before and after treatment change and HbA1c, BMI immediately before and one month after the channge.	—

Countries

Japan

Contacts

Public ContactArina Miyoshi

Sapporo City General Hospital Department of Diabetes and Endocrinology

arina.miyoshi@doc.city.sapporo.jp011-726-2211

Outcome results